Evidence map›Paper›PMID 41798509›Full record

ArticleCureus2026

Bednar Tumor: A Rare Variant of Dermatofibrosarcoma Protuberans.

Michelle Alcocer Salas, Diana L Vazquez-Cantu, Bryan Salvador Sol Tlapalamatl, Mercedes Hernández Torres, José Alfredo Soto-Ortiz

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michelle Alcocer SalasDermatology, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Zapopan, MEX.
Diana L Vazquez-CantuDermatology, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Zapopan, MEX.
Bryan Salvador Sol TlapalamatlDermatology, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Zapopan, MEX.
Mercedes Hernández TorresDermatopathology, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Zapopan, MEX.
José Alfredo Soto-OrtizDermatology, University of Guadalajara, Guadalajara, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare dermal sarcoma of intermediate malignancy characterized by locally aggressive behavior and a low metastatic potential. The classic form typically presents as a slow-growing protuberant tumor involving the trunk or proximal extremities; however, several uncommon variants have been described. We report the case of a 32-year-old woman who presented with a long-standing pigmented lesion on the shoulder that had been present since childhood and showed progressive changes over the preceding six months. Clinically, the lesion evolved into an oval-shaped neoplasm with erythematous and brown pigmentation, a smooth surface, and an infiltrative consistency. Based on the clinical features, a diagnosis of DFSP was suspected, with particular consideration given to its rare pigmented variant, known as Bednar tumor. Histopathological examination and immunohistochemical analysis were performed to confirm the diagnosis and guide management. Although Bednar tumor exhibits distinctive histologic features due to the presence of melanin-producing dendritic cells, its biological behavior and prognosis are similar to those of conventional DFSP. Notably, only three cases of DFSP have been diagnosed over a 13-year period at a tertiary dermatology referral center in western Mexico, underscoring the rarity of this entity and the importance of clinical awareness for timely diagnosis and appropriate treatment.

Indexed as

bednar tumorcutaneous sarcomadermatofibrosarcoma protuberansimmunohistochemistrypigmented

Identifiers

PMID41798509
PMCPMC12965016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.